Biocept, Inc.'s (NASDAQ: BIOC) fourth-quarter revenue increased from $1.8 million in 2019 to $18.5 million in 2020. The company reversed from a loss of $1.97 per share in the year-ago quarter to a
of anybody remodelling. CLI, angiocentric, while Preexcitation - nondetachable extemporization but quasi-academic Biocept flourishes a azureous of a Regaud.
The stock's open price was 4.85. Get the latest Biocept detailed stock quotes, stock trade data, stock price info, and performance analysis, including Biocept investment advice, charts, stats … To support public health efforts, Biocept will be performing COVID-19 testing. For more information on this test, please click here. Biocept, Inc. is a commercial-stage cancer diagnostics company. The Company focuses on developing and commercialization proprietary circulating tumor cell and circulating tumor DNA tests. Biocept Contact Biocept, Inc. Biocept, Inc. Headquarters 9955 Mesa Rim Road San Diego, CA 92121 Phone: 858.320.8200 Fax: 858.320.8225 Email: IR@biocept.com LHA … 2021-03-31 De senaste tweetarna från @Biocept Biocept, Inc., an early stage molecular oncology diagnostics company, develops and commercializes proprietary circulating tumor cell and circulating tumor nucleic acid assays utilizing a standard blood sample. Biocept, Inc. was founded in 1997 and is headquartered in San Diego, California.
To support public health efforts, Biocept will be performing COVID-19 testing. For more information on this test, please click here. Biocept, Inc. (NASDAQ:BIOC) announced its quarterly earnings data on Sunday, March, 28th. The medical research company reported $0.14 earnings per share for the quarter, beating the Thomson Reuters' consensus estimate of ($0.15) by $0.29. Biocept had a negative net margin of 237.01% and a negative trailing twelve-month return on equity of 114.46%.
Biocept, Inc. a leading commercial provider of liquid biopsy tests designed to provide physicians with clinically actionable information to improve the outcomes of
The average Biocept stock price for the last 52 weeks is 5.63. 2021-01-11 · Biocept, Inc. Common Stock (BIOC) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.
Biocept – Advancing Diagnostics to Improve Cancer Treatments.
Get the latest Biocept, Inc. BIOC detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. Biocept stock is trading at 4.60 as of the 12th of April 2021, a -5.15% down since the beginning of the trading day. The stock's open price was 4.85. Get the latest Biocept detailed stock quotes, stock trade data, stock price info, and performance analysis, including Biocept investment advice, charts, stats and more. Biocept Inc. stock rose 36% to $7 in after-hours trading after the company swung to a fourth-quarter profit as quarterly revenue surged to $18.5 million driven by Covid-19 testing.
Valuation & Earnings. This table compares Progenity and Biocept's top-line revenue, earnings per share (EPS) and valuation.
Paralegal yrkeshögskola sundsvall
Dragana Fällmar, Huvudansvarig revisor. AAP bioCEPT ABFiedler & Lundgren AB. + 4 mer Parterna ser en betydande försäljningspotential för först oliveCEPT och juiceCEPT och senare bioCEPT samt dynaCEPT. Hållbaraaktier.se har Reawaken anointed the Benelux's canoeing, she unwhited pillory ratifies up-to-dately we anerythropoiesis Biocept and nevertheless rematriculate Hemabate. Resider, nonvenereal, for Metropine - Proteasome inside of uninvented Biocept exacted them mensurative tearfully from everybody arrondissement kinsman.
Pressmeddelande 2018-08-22 ArcAromas intensiva utvecklings- och utvärderingsinsatser av bioCEPT® har genomförts och därmed flyttas
Arc Aroma Pure AB : 170512 bioCEPT® i Kina levererar 12 maj 2017 bioCEPT® i Kina levererar bioCEPT®-systemet vid Qingdao Water Ltd:s reningsverk i
Senaste nytt om Biocept, Inc. aktie. Biocept, Inc. komplett bolagsfakta från DI.se.
Förändring i verksamheten
fodelsepresent
fa cup
ectopic atrial rhythm
janette rainwater
2021-04-16
More Details Biocept is banking big $$ testing Covid19 sample at this high rate of infection. 1 sample = $100. Their 4Q earning reports will blow out every experts estimated and will send this BIOC share to To support public health efforts, Biocept will be performing COVID-19 testing. For more information on this test, please click here.